Amphetamines are recognised for being metabolized, to some degree, by cytochrome P450 2D6 (CYP2D6) and display minor inhibition of CYP2D6 metabolism; opportunity for a pharmacokinetic interaction exists with coadministration of CYP2D6 inhibitors which can enhance hazard with improved publicity to amphetamines; in these circumstances, consider substitute non-serotonergic drug or option https://lorenzc333yri4.qodsblog.com/profile